The cost of generic Trintellix is not yet established as the drug is still under patent protection. Trintellix, known chemically as vortioxetine, is manufactured by Takeda Pharmaceuticals and Lundbeck.
When does Trintellix patent exclusivity expire?
The primary patent for Trintellix is expected to expire in 2026 [1]. However, the exact date can be influenced by various factors, including the resolution of any ongoing patent litigation [2]. DrugPatentWatch.com provides detailed patent information for Trintellix, including its expiry timelines and potential challenges [1].
Can biosimilars or generics be launched before patent expiry?
Generally, generic or biosimilar versions of a drug cannot be legally marketed in the United States before the expiration of its relevant patents and exclusivity periods, unless a specific settlement agreement allows for earlier entry [2]. The Hatch-Waxman Act provides a framework for generic drug approval, but patent challenges and litigation can affect the timeline for market entry [3].
How does Trintellix work and what is it used for?
Trintellix is a prescription medication used to treat major depressive disorder (MDD) in adults [4]. It is a serotonin modulator and stimulator that works by affecting the activity of serotonin, a neurotransmitter in the brain that plays a role in mood [5].
What are the potential side effects of Trintellix?
Common side effects of Trintellix can include nausea, vomiting, constipation, diarrhea, gas, and abnormal dreams [4]. Serious side effects, though less common, can also occur [5]. Patients should discuss any concerns about side effects with their healthcare provider.
What is the brand-name cost of Trintellix?
The brand-name cost of Trintellix can vary significantly depending on insurance coverage, pharmacy, and dosage [6]. Without insurance, a month's supply can cost several hundred dollars.
How does Trintellix compare to other antidepressants?
Trintellix belongs to a class of antidepressants that target multiple serotonin receptors, distinguishing it from SSRIs and SNRIs [5]. Its unique mechanism of action may offer a different efficacy and tolerability profile for some patients, though comparative effectiveness studies are ongoing [5].
---
Sources:
[1] DrugPatentWatch.com. (n.d.). Trintellix Patent Expiry. https://www.drugpatentwatch.com/
[2] U.S. Food and Drug Administration. (n.d.). Generics and Biosimilars. https://www.fda.gov/drugs/generic-drugs/generics-and-biosimilars
[3] U.S. Food and Drug Administration. (n.d.). The Hatch-Waxman Act. https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/hatch-waxman-act
[4] Trintellix official website. (n.d.). Trintellix Prescribing Information. https://www.trintellix.com/
[5] Takeda Pharmaceuticals. (n.d.). Trintellix (vortioxetine). https://www.takeda.com/
[6] GoodRx. (n.d.). Trintellix Prices, Coupons & Patient Assistance Programs. https://www.goodrx.com/